A recent editorial published in the Annals of Internal Medicine argues that multivitamins should not be used for chronic disease prevention, and consumers should “stop wasting money” on these products.

While the tone and content of the AIM editorial and reports are certainly open to debate, this pronouncement may raise concerns among supplement manufacturers and distributors about their advertising and their vulnerability to potential consumer false advertising claims.

Read the entire article at www.NortonRoseFulbright.com.

The authors include Norton Rose Fulbright lawyers: Saul Perloff and Kathy Grant of the US Intellectual property group, Jeff Margulies and Stephanie Stroup of the US Dispute resolution and litigation group.